ELECTROLYTE CONCENTRATE FOR INJE. Key specifications include special_features: 25 ML IN A 50 ML PARTIAL-FILL VIAL; TO BE DILUTED BEFORE INJECTION, primary_container_type: VIAL, total_primary_container_quantity: 100, primary_container_content_quantity: 25.000 MILLILITERS. This product is currently in active production with full OEM support.
This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-096-6394, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | 25 ML IN A 50 ML PARTIAL-FILL VIAL; TO BE DILUTED BEFORE INJECTION |
| primary_container_type | VIAL |
| total_primary_container_quantity | 100 |
| primary_container_content_quantity | 25.000 MILLILITERS |
| NSN | 6505-01-096-6394 |
| PRIMARY CONTAINER CONTENT QUANTITY | 25.000 MILLILITERS |
| PRIMARY CONTAINER TYPE | VIAL |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 5.000 MILLIEQUIVALENTS CALCIUM ACTIVE INGREDIENT AND 33.500 MILLIEQUIVALENTS CHLORIDE ACTIVE INGREDIENT AND 8.000 MILLIEQUIVALENTS MAGNESIUM ACTIVE INGREDIENT AND 40.500 MILLIEQUIVALENTS POTASSIUM ACTIVE INGREDIENT AND 25.000 MILLIEQUIVALENTS SODIUM ACTIVE INGREDIENT AND 40.600 MILLIEQUIVALENTS ACETATE ACTIVE INGREDIENT AND 4.000 MILLIEQUIVALENTS GLUCONATE ACTIVE INGREDIENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 100 |
| SPECIAL FEATURES | 25 ML IN A 50 ML PARTIAL-FILL VIAL; TO BE DILUTED BEFORE INJECTION |